The key to the myeloma research is to have an IRB trial in
The key to the myeloma research is to have an IRB trial in Israel coupled with an FDA submission for the same trials.
The FDA can't(or won't) approve a plant cannabis trial in the US, but it can't deny one that takes place in Israel. (Fact, it's already done)
IMO, OWC is gaming the US system. Look how they are doing it with the cream. Get accepted for FDA safety trial. Since no trial can be legally done in the US with plant based cannabis, it's being done in Israel. The results are then forwarded to the FDA which the FDA must under treaty accept. And let's not forget the political aspect of it either. Israel is a protected state of the US.
Then comes Phase II and III. Must be accepted by the FDA's own rules.
So OWC files for an IRB in Israel for Phase I of the myeloma treatment. Does the same in the US since the treaty says it can be so. Bingo, we are off and running for future Phase trials that are submissible and acceptable by the FDA because of the politics. Will be accepted at a 80% yes, 20% no. But the trials are done in Israel since it is legal there and not the US. Brilliant
The management of OWC is not to be messed with and they are not playing games although it may seem like it. They know the system and have brought top notch folks on board to play the game, only they are not playing. This is why it is taking time to see results.
"This is White Rook to Queen's Bishop, Over?"
Tell ya what all. OWC is playing for keeps. This is high politics and finance rolled into one. Heck, what will the name of the movie be in 15 years.
Try this, Heaven Helped Us
The story of how an obscure Israeli startup pharma company, through it's relentless research, helped mankind find a better way through the God given cure know as cannabis. A David vs Goliath action film in the financial columns of Wall Street to the Halls of Congress. The gripping true story of the fight or survival of mankind
Okay, got carried away. It was boring with the price, so ya'll get this. True though IMHO.
8
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
BlueCollar Cloud Aligns with SuiteWorld 2026 If you thought the construction ERP space was just a dusty office in a backlot, think again. BlueCollar Cloud is strapping on its boots and diving into the heart of SuiteWorld 2026 with a platinum sponsorship. This isn't just a walk in the park—it's a strategic power move, aligning themselves smack-dab in the middle of...
Continue Reading
Revolutionizing Film Financing The film industry has always been a tough nut to crack. Imagine trying to keep your creative baby yours without surrendering the crown jewels of intellectual property. Well, now, the cavalry with a fresh game plan has arrived, and both investors and filmmakers might be ready for another round. This isn't the typical PR fairytale; it's...
Continue Reading
A New Leaf in Gutter Maintenance From the ground up, EZ Elephant is redefining how we tackle gutter maintenance. Picture it: never having to teeter on that wobbly ladder again just to unclog your gutters. This American-made solution, showcased at the Western Roofing Expo from September 27–29, 2026, is a game changer. Check out Booth #834 to see this marvel of innovation...
Continue Reading
Navigating the AI Maze: Flux's New Pathways Ever feel like these engineering platforms speak a language of their own? Flux's latest expansion finally offers a translator that matters. It's all about decoding whether your AI investment is delivering the goods. Engineering leaders now have more than just fluffy metrics; Flux breaks down real code-based evidence to show if...
Continue Reading
Ever found a protein shake that tastes like a candy bar from the future? Well, Hi-Tech Pharmaceuticals is banking on their new Dubai Chocolate flavor to hit that sweet spot. This isn't your typical powdered shake game; Hi-Tech's been cranking the flavor dial ever since they introduced their Precision Protein® line back in 2016. They've carved out a niche with unique...
Continue Reading
Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...
Continue Reading
Stepping Boldly into the Livestreaming Arena There's a new kid in the chaotic neighborhood of social media, and it's called GoLive Streamers. Not just another aimless stroll down Content Highway, GoLive is weaving its own defining path by fostering genuine real-time interaction. Launched in April 2026, this plucky platform has quickly amassed a following of over 74,000...
Continue Reading
Greasezilla is shaking up the world of waste management, folks. With municipal sewer systems clogged by fats, oils, and grease, Greasezilla's no-nonsense approach is a breath of fresh air. They've just fired up their new regional hub in Ashland, Virginia, taking another hefty step towards easing this burden on municipalities. This ain't small potatoes—this national...
Continue Reading
Something's Buzzing at the Big Board Walk over to Wall Street on September 23rd, and guess what you get? A lot more than just stock tickers blinking away. First Lady Melania Trump’s stealing the show at the New York Stock Exchange to kick off the inaugural IMPERIA Summit. She’s there to sound the opening bell and lead the charge in a summit that's focused on the...
Continue Reading
Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...
Continue Reading
Top 5 Most Recently Viewed Articles
Xobin Recognized in the 2024 Gartner Market Guide Xobin, a leading skills assessment software company, proudly announces its recognition in the 2024 Gartner Market Guide for Developer Skills Assessment and Interview Platforms. This acknowledgment underscores Xobin's commitment to providing organizations with innovative and efficient hiring solutions. The Impact of Xobin's...
Continue Reading
BioVaxys Advances with Debt Settlement Agreement BioVaxys Technology Corp. (CSE: BIOV) continues to make significant strides in its financial operations. Recently, the company revealed that it has successfully entered into debt settlement agreements with several arm's-length consultants to manage over $207,000 in outstanding debt. In this arrangement, BioVaxys has opted...
Continue Reading
CalciMedica Highlights CARDEA Trial Data on Auxora CalciMedica Inc. (NASDAQ: CALC), a clinical-stage biopharmaceutical company, made significant strides in its ongoing clinical research with the presentation of new findings from the CARDEA trial involving Auxora™. Recently presented at an esteemed international conference, these findings shed light on the potential of...
Continue Reading
AbbVie Appoints Robert A. Michael as Chairman of the Board AbbVie (NYSE: ABBV) recently announced the unanimous decision of its board of directors to elect Robert A. Michael as the new chairman, following Richard A. Gonzalez's retirement. This significant change in leadership is set to take place on July 1, 2025. Michael, currently serving as the CEO, will lead the...
Continue Reading
Understanding Recent Stock Sales by Flex Ltd Recently, Erin McSweeney, the Director at Flex Ltd (NASDAQ: FLEX), made headlines by selling a significant portion of her shares. According to the latest SEC filings, this transaction involved 10,000 shares with a total value of $514,711. Current Market Performance of Flex Ltd As of Tuesday morning, Flex shares are experiencing...
Continue Reading
